News Detail
London, 21 June 2024: The UK Medicines and Healthcare products Regulatory Agency (MHRA) is introducing new safety measures for topiramate after a study has shown an increased risk of neurodevelopmental disabilities in children whose mothers took the drug during pregnancy. View Details
Source : Pharmaceutical Technolgy
UK Medicines and Healthcare products Regulatory Agency
MHRA
topiramate
Related News
- Import dependence on key pharma ingredients may reduce by half (14-11-2024)
- Banned Cough Syrup worth one crore seized, three drug dealers arrested (13-11-2024)
- Two factories making fake Veterinary Medicines busted in Agra, operators detained (13-11-2024)
- DCA officials continue drive against unlicenced medical shop, quacks, overpriced medicines and misleading Ayurvedic medicines (13-11-2024)
- CSIR-IIIM signs MoU with LAHDC to set up farm to cultivate medicinal plants in Ladakh (13-11-2024)
- IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms (13-11-2024)
- India needs to expand local vaccine manufacturing, research: GTRI report (13-11-2024)
- Telangana to set up four new drug testing labs (13-11-2024)
- Punjabi singer Chhinda was running the fake medicine factory in Mohali, three luxury cars recovered (13-11-2024)
- 2400 Banned cough syrup Bottles recovered, 2 arrested (13-11-2024)